k19 ; k1cs ; Keratin 19 Keratin Type i 40kD ; krt19
Categories
Primary Antibodies
Cellular Localization
Cytoplasmic
Chromosome Location
17q21.2
Clonality
Monoclonal
Description
This MAb reacts with the rod domain of human cytokeratin-19 (CK19), a polypeptide of 40kDa. CK19 is expressed in sweat gland, mammary gland ductal and secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus, and ectocervical epithelium. Anti-CK19 reacts with a wide variety of epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although 50%-60% of follicular carcinomas are also labeled. Anti-CK19 is a useful marker for detection of tumor cells in lymph nodes, peripheral blood, bone marrow and breast cancer.
Host
Mouse
Immunogen
Human breast cancer MCF-7 cells (A53-B/A2); Human mammary epithelial organoids (BA17)
Isotype
IgG1, IgG2a Kappa
Positive Control
MCF-7, HeLa, Hep-G2 cells, Breast Cancer
Reactivity
Human
Recombinant
FALSE
Regulatory
RUO
Swissprot
P08727
Uniprot
654568
Gene Id
3880
Buffer
200μg/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
Concentration
1.0mg/ml
Description
There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
Purity
Purified Ab WITHOUT BSA and Azide at 1.0mg/ml
Applications
FACS, IF, IHC-F
Description
(Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes); Optimal dilution for a specific application should be determined., FACS ; IF ; IHC-F
Dilution
FACS
0.5-1μg/million cells in 0.1ml
IF
1-2μg/ml
IHC-F
0.5-1μg/ml for 30 min at RT
Reviews of Anti-Cytokeratin 19 (KRT19) Antibody BHA10202945